.svg){kind=small}
Jan-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Farmaceutical Rx (Frx) has shown notable performance in the Ohio market across various product categories. In the concentrates category, the brand has made significant strides, climbing from outside the top 30 in October 2024 to rank 10th by January 2025. This upward trajectory indicates a strong consumer response and increasing market penetration. The flower category also shows a steady performance with Frx maintaining a presence in the rankings, although it experienced a slight dip from 32nd in December 2024 to 34th in January 2025. This suggests a need for strategic adjustments to maintain or improve its standing in this competitive segment.
Conversely, the vapor pens category presented mixed results for Farmaceutical Rx (Frx) in Ohio. While the brand improved its ranking from 38th in October to 29th in December 2024, it saw a dramatic drop to 53rd by January 2025. This decline could be indicative of increased competition or shifts in consumer preferences. Interestingly, Frx did not secure a top 30 position in the edible category, which might highlight an area for potential growth or reevaluation. Overall, the brand's performance across these categories suggests areas of both strength and opportunity, with particular attention needed in categories where rankings have declined or are absent.
Competitive Landscape
In the competitive landscape of the Ohio flower category, Farmaceutical Rx (Frx) has demonstrated a notable upward trend in rankings over the past few months, moving from 38th in October 2024 to 34th by January 2025. This upward trajectory is indicative of a strengthening position in the market, particularly as competitors like Moxie and Curaleaf have experienced declines in their rankings, with Moxie dropping from 24th to 35th and Curaleaf fluctuating significantly, even though Curaleaf saw a spike in December. Meanwhile, Verano and Josh D have maintained relatively stable positions, with Verano slightly improving from 36th to 33rd and Josh D from 31st to 32nd. This suggests that Farmaceutical Rx (Frx) is gaining ground in a competitive market, potentially due to strategic initiatives or product offerings that resonate well with consumers, as reflected in their sales growth from October to December, before a slight dip in January.
Notable Products
In January 2025, Milkbone (2.83g) continued its reign as the top-performing product for Farmaceutical Rx (Frx), maintaining its number one rank from previous months with a notable sales figure of 2095 units. Following closely, Hot Sauce #9 (2.83g) retained its second-place position from December, although its sales figures saw a decrease compared to the previous month. A new entry into the rankings, Creamsicle Distillate Cartridge (0.5g), made a strong debut at third place, indicating a growing interest in vapor pens. OG Watermelon Distillate Cartridge (0.5g) and Banana Sherbert Live Resin Badder (1g) followed, securing fourth and fifth places respectively, marking their first appearances in the top five. This shift in rankings suggests an increasing consumer preference for vapor pens and concentrates alongside traditional flower products.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
